Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure-Reference-Cited by-同舟云学术

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure

Published:2021-03 Issue:11 Volume:77 Page:1397-1407
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ferreira João Pedro,Zannad Faiez,Pocock Stuart J.,Anker Stefan D.,Butler Javed,Filippatos Gerasimos,Brueckmann Martina,Jamal Waheed,Steubl Dominik,Schueler Elke,Packer Milton

Funder

Boehringer Ingelheim GmbH

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011

2. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N Engl J Med,1999

3. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med,2019

4. Cardiovascular and renal outcomes with empagliflozin in heart failure;Packer;N Engl J Med,2020

5. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials;Zannad;Lancet,2020

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of macrophage polarization in heart failure and traditional Chinese medicine treatment;Frontiers in Pharmacology;2024-07-18

2. Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction;European Heart Journal;2024-05-28

3. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC;European Journal of Heart Failure;2024-05-22

4. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21

5. Empagliflozin in the treatment of heart failure;Future Cardiology;2024-04-25